Levothyroxine pharmacology
Pro Research Analysisby 
Searched over 200M research papers for "levothyroxine pharmacology"
Levothyroxine Pharmacology: Mechanism, Absorption, and Metabolism
Levothyroxine is a synthetic form of thyroxine (T4), a hormone naturally produced by the thyroid gland. It is primarily used to treat hypothyroidism and as suppressive therapy in thyroid cancer and nodular thyroid disease 25. Levothyroxine acts as a prohormone, being converted in the body to the more active triiodothyronine (T3), which then regulates gene transcription and metabolic processes in various tissues 25.
After oral administration, about 80% of levothyroxine is absorbed in the small intestine, with absorption rates decreasing further along the intestinal tract 235. Peak serum T4 levels are typically reached 2 to 4 hours after ingestion, and the drug is highly protein-bound in the bloodstream, with only the free fraction being biologically active 25. Levothyroxine is metabolized mainly by deiodination to T3, as well as by other pathways such as sulfation and glucuronidation .
Levothyroxine Formulations and Bioequivalence
Levothyroxine is available in several oral formulations, including tablets, soft gel capsules, and oral solutions . Both brand-name and generic versions exist, and regulatory agencies like the FDA use serum T4 levels in healthy volunteers to determine bioequivalence between products . However, this method has been criticized for not considering thyroid-stimulating hormone (TSH) levels and for using healthy individuals rather than patients with thyroid disease . Even small differences in bioavailability between formulations can lead to significant changes in TSH, which is especially concerning for vulnerable populations such as the elderly, pregnant women, and children .
Switching between different levothyroxine formulations or brands can result in altered efficacy and adverse events, sometimes due to differences in excipients. It is generally recommended that patients remain on the same preparation, and if a change is necessary, TSH levels should be monitored and the dose adjusted as needed .
Factors Affecting Levothyroxine Absorption and Bioavailability
Drug and Food Interactions
Many medications and foods can interfere with levothyroxine absorption and bioavailability. Common interfering substances include calcium and iron supplements, proton pump inhibitors, bile acid sequestrants, phosphate binders, sex hormones, and anticonvulsants 346. Certain foods and beverages, such as coffee, soy products, fiber, milk, juices, and enteral nutrition, can also reduce absorption 46. The mechanisms of these interactions include direct binding (chelation), changes in gastric pH, and alterations in thyroxine-binding proteins or metabolic pathways 46.
To minimize these interactions, levothyroxine should be taken on an empty stomach, at least 30 minutes before breakfast and separated from other medications or supplements by several hours 456. Newer formulations, such as liquid solutions and soft-gel capsules, may help overcome some absorption issues caused by food or drug interactions 46.
Gastrointestinal Disorders
Gastrointestinal diseases, such as celiac disease, lactose intolerance, and inflammatory bowel disease, can impair levothyroxine absorption and lead to refractory hypothyroidism . Identifying and managing these underlying conditions is important for optimizing therapy .
Dosing, Monitoring, and Safety
The initial dose of levothyroxine depends on the patient’s weight, residual thyroid function, and treatment purpose 25. Dose adjustments are guided by TSH measurements, with the goal of maintaining TSH within the normal range for replacement therapy or below normal for suppressive therapy . During pregnancy, levothyroxine requirements typically increase by about 45%, and more frequent monitoring is recommended .
Excessive levothyroxine administration can lead to symptoms of hyperthyroidism, including palpitations, increased heart rate, and decreased bone mineral density, especially in women 25. Over-replacement is a common issue, highlighting the importance of regular TSH monitoring .
Conclusion
Levothyroxine is a cornerstone therapy for hypothyroidism and thyroid cancer, with its pharmacology influenced by formulation, absorption, drug and food interactions, and patient-specific factors. Consistent use of the same formulation, careful attention to administration timing, and regular TSH monitoring are essential for safe and effective therapy 1234+2 MORE.
Sources and full results
Most relevant research papers on this topic